Hensoldt's €10 Billion Horizon: Two Banks Agree on €105, but the Clock Is the Judge
Published on 11/12/2026 at 08:51 | Editorial boerse-global.de
Hensoldt has spent years asking investors to trust the order book. After this week's capital markets day, the question has shifted: can the order book be turned into revenue fast enough to satisfy a market that has already priced in a good deal of the promise?
The Frankfurt-listed defence electronics group gave its answer on Tuesday, and it stretched further into the future than ever before. Alongside a reconfirmed €6 billion revenue ambition for 2030, management set out a long-term target of €10 billion in sales by 2035 — the first time the company has put a number on that horizon. Growth of 15% to 20% a year is expected for 2027 and 2028, with the adjusted EBITDA margin climbing to around 21% by 2030.
Those figures build on a business that is already outgrowing its own delivery. In the first nine months of fiscal 2026, Hensoldt booked orders worth €3.56 billion against revenue of €1.86 billion, lifting the order backlog to €10.4 billion. Adjusted EBITDA for the period came in at €281 million. Roughly a week before the capital markets day, the company had sharpened its full-year 2026 guidance to revenue of around €2.8 billion and an adjusted EBITDA margin of about 19.0%.
The analyst split that wasn't
The immediate market reaction was muted — the stock slipped 1.6% — but the brokerage response told a more interesting story. Stifel raised its price target to €105 from €90 while reiterating its Buy rating. JPMorgan moved to the same €105 mark, up from €100, and lifted its rating from Neutral to Overweight. Analyst Lucy Fitzgerald framed Hensoldt as a long-term winner, saying the capital markets day had reinforced confidence in the company's investment plans and growth trajectory.
Should investors sell immediately? Or is it worth buying Hensoldt?
Deutsche Bank Research went the other way on the target, trimming to €100 from €105 while keeping its Buy recommendation. Analyst Christophe Menard said the growth path had come in somewhat below his initial estimate, though the long-term objectives still convinced him. So two houses now sit at €105 with positive ratings, a third holds a Buy at €100 — directionally aligned, divided only on pace.
Where the scepticism actually lives
That divergence over tempo has a concrete anchor. According to media reports, the full-year revenue guidance landed below the analyst consensus, and the initial share price weakness was attributed in part to broader softness across the German defence sector. The same reports suggest investors are now focusing more intently on how the record order book converts into sales.
For anyone valuing Hensoldt on its backlog, the story is about tomorrow's business. For anyone valuing it on execution, the demand is for a credible bridge into the earnings line. Both views collide in this stock, and that collision explains the tension between long-term optimism and differing expectations about the growth path.
The intermediate milestones deserve more attention than the distant €10 billion marker. They will show sooner whether Hensoldt can hit the pace it has set itself. The long-term case gains weight only if the expected acceleration actually shows up in the numbers — and if the high order intake reliably becomes more business at the margin the company says it can reach. That, rather than the size of the backlog, is what will decide the quality of the next stage of growth.
Ad
Hensoldt Stock: New Analysis - 12 November
Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
